What are the appropriate work‑up steps for a suspected myocardial infarction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Work-up of Myocardial Infarction

The work-up of suspected myocardial infarction requires immediate ECG acquisition within 10 minutes of presentation, followed by serial cardiac troponin measurements, with repeat ECGs at 15-30 minute intervals if the initial tracing is non-diagnostic 1.

Immediate Diagnostic Steps

1. Electrocardiogram (ECG)

  • Obtain and interpret within 10 minutes of clinical presentation 1

  • Look specifically for:

    • ST-segment elevation: ≥0.2 mV in men ≥40 years, ≥0.25 mV in men <40 years, ≥0.15 mV in women in leads V2-V3; ≥0.1 mV in all other leads 1
    • New Q waves (likelihood ratio 5.3-24.8 for MI) 2
    • ST-segment depression: ≥0.05 mV horizontal or down-sloping in two contiguous leads 1
    • T wave inversion: >0.1 mV in two contiguous leads 1
    • New left bundle branch block
    • Cardiac arrhythmias, conduction delays, loss of precordial R wave amplitude 1
  • Serial ECGs are mandatory: If initial ECG is non-diagnostic but symptoms persist, repeat at 15-30 minute intervals 1

  • Compare to prior ECGs when available to identify new changes 1

  • Use posterior leads (V7-V9) at the fifth intercostal space to capture left circumflex territory ischemia, which is frequently overlooked 1

2. Cardiac Biomarkers

  • Troponin T or I is the preferred marker and must be measured 3
  • Serial measurements are essential: Single troponin measurement is insufficient
  • With high-sensitivity troponin assays, repeat measurement at 1-3 hours can facilitate rapid rule-in or rule-out 4
  • Elevated troponin plus ischemic symptoms and/or ECG changes = MI diagnosis 3

3. Focused Clinical Assessment

Look for specific high-yield features that increase MI probability:

  • Chest pain radiating to both arms simultaneously (likelihood ratio 7.1) 2
  • Third heart sound (S3) on auscultation (likelihood ratio 3.2) 2
  • Hypotension (likelihood ratio 3.1) 2

Features that decrease MI probability:

  • Pleuritic chest pain (likelihood ratio 0.2) 2
  • Chest pain reproduced by palpation (likelihood ratio 0.2-0.4) 2
  • Sharp or stabbing pain (likelihood ratio 0.3) 2
  • Positional chest pain (likelihood ratio 0.3) 2

Algorithmic Approach to Interpretation

When ECG Shows ST-Elevation or New LBBB

  • Diagnose STEMI immediately
  • Proceed directly to reperfusion strategy (primary PCI or fibrinolysis if PCI cannot be performed within 120 minutes) 5

When ECG is Non-Diagnostic but Symptoms Persist

  • Repeat ECG every 15-30 minutes 1
  • Obtain serial troponin measurements
  • Consider continuous 12-lead ECG monitoring if available 1
  • Do not delay treatment while waiting for biomarkers if clinical suspicion is high

When Troponin is Elevated but ECG is Non-Diagnostic

Consider the pre-test probability based on:

  1. Chest pain characteristics and onset timing 4
  2. Presence of alternative explanations: age-related elevation, heart failure, aortic stenosis, pulmonary embolism 4
  3. Additional testing may include: echocardiography, stress testing, or cardiac MRI 4

Critical Pitfalls to Avoid

  • Do not rely on ECG alone: ST-segment deviation can occur in pericarditis, left ventricular hypertrophy, LBBB, Brugada syndrome, stress cardiomyopathy, and early repolarization 1
  • Do not miss left circumflex territory infarction: Use posterior leads 1
  • Do not accept a single normal troponin: Serial measurements are mandatory 3
  • Do not dismiss patients who die before biomarkers return: If clinical features and ECG changes suggest MI, classify as fatal MI even without biomarker confirmation 1

Risk Stratification

Once MI is diagnosed, additional markers improve risk assessment:

  • CRP and BNP/NT-proBNP help identify high-risk patients who benefit from more aggressive therapy 3
  • Elevated troponin identifies patients who benefit from antithrombotic therapy and invasive procedures 3

The normal ECG has the strongest negative predictive value (likelihood ratio 0.1-0.3) for ruling out MI 2, but serial assessment remains necessary if clinical suspicion persists.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.